By mimicking GLP-1, semaglutide helps you feel fuller for longer, reducing cravings and making it easier to stick to a healthy diet
While effective for obesity management, ongoing research and vigilant patient monitoring are essential to address and mitigate potential risks associated with GLP-1 RAs [87] [88]
Funding Sponsorship for this study was funded by Novo Nordisk Inc
People with insulin resistance manifest impaired insulin action in all insulin target organs/tissues including skeletal muscle, cardiac muscle, liver, adipose tissue, and brain, as well as the vasculature
10.1016/j.freeradbiomed.2008.03.011 [DOI] [PMC free article] [PubMed] [Google Scholar] Lewis CA, Parker SJ, Fiske BP, McCloskey D, Gui DY, Green CR, Vokes NI, Feist AM, Vander Heiden MG, Metallo CM
IS IGF-1LR3 SAFE